Clarus Therapeutics, Inc. announced the expansion of its Board of Directors from six to eight with the appointments of Ms. Elizabeth (Liz) A. Cermak and Mr. Mark A. Prygocki, Sr., effective July 10, 2014. Most recently, Ms. Cermak was Executive Vice President, Chief Commercial Officer and member of the Executive Committee of POZEN, Inc. Mr. Prygocki most recently served as President of Medicis Pharmaceutical Corporation.